Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.86 - $1.53 $25,691 - $45,707
-29,874 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.15 - $2.25 $2,419 - $4,734
-2,104 Reduced 6.58%
29,874 $45,000
Q4 2021

Feb 11, 2022

SELL
$2.04 - $3.59 $1,950 - $3,432
-956 Reduced 2.9%
31,978 $69,000
Q3 2021

Nov 12, 2021

SELL
$3.53 - $5.89 $23,912 - $39,898
-6,774 Reduced 17.06%
32,934 $117,000
Q2 2021

Aug 13, 2021

SELL
$3.77 - $6.0 $6,910 - $10,998
-1,833 Reduced 4.41%
39,708 $228,000
Q1 2021

May 07, 2021

BUY
$2.39 - $6.5 $11,895 - $32,350
4,977 Added 13.61%
41,541 $216,000
Q4 2020

Feb 12, 2021

SELL
$1.38 - $2.63 $1,449 - $2,761
-1,050 Reduced 2.79%
36,564 $87,000
Q3 2020

Nov 04, 2020

BUY
$1.2 - $1.89 $13,388 - $21,086
11,157 Added 42.17%
37,614 $52,000
Q2 2020

Aug 12, 2020

BUY
$1.91 - $3.45 $25,231 - $45,574
13,210 Added 99.72%
26,457 $51,000
Q1 2020

May 04, 2020

SELL
$1.76 - $3.02 $374 - $643
-213 Reduced 1.58%
13,247 $32,000
Q4 2019

Feb 05, 2020

SELL
$1.51 - $2.27 $172 - $258
-114 Reduced 0.84%
13,460 $30,000
Q3 2019

Nov 08, 2019

SELL
$1.59 - $2.51 $149 - $235
-94 Reduced 0.69%
13,574 $29,000
Q2 2019

Aug 13, 2019

BUY
$2.49 - $5.45 $34,033 - $74,490
13,668 New
13,668 $34,000
Q2 2018

Aug 08, 2018

SELL
$2.0 - $3.3 $4,912 - $8,104
-2,456 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$1.25 - $4.6 $165 - $607
-132 Reduced 5.1%
2,456 $5,000
Q4 2017

Feb 09, 2018

BUY
$3.9 - $7.4 $682 - $1,295
175 Added 7.25%
2,588 $12,000
Q3 2017

Nov 09, 2017

BUY
$4.55 - $7.55 $10,979 - $18,218
2,413
2,413 $18,000

Others Institutions Holding OCX

About Oncocyte Corp


  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $260M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.